Hereditary Diffuse Gastric Cancer Syndrome

Top Cited Papers
Open Access
Abstract
Quiz Ref ID Gastric cancer (GC) is the third most common cause of cancer-related mortality worldwide.1 The 2 major subtypes, diffuse GC (DGC) and intestinal-type GC, are distinguished by molecular, epidemiologic, and morphologic features.2 Although GC is usually sporadic, familial aggregation occurs in approximately 10% of cases.3,4 Quiz Ref ID Clinically defined hereditary DGC (HDGC) (OMIM #137215) is characterized by early-onset, multigenerational DGC and lobular breast cancer. Clinical criteria for this entity was established by the International Gastric Cancer Linkage Consortium (IGCLC) (Table 1).5,6 Approximately 40% of HDGC families have germline mutations in CDH1 (E-cadherin) (Ensembl ENSG00000039068; OMIM *192090), and over 100 different pathogenic germline mutations are reported across multiple ethnicities (eTable 1 in the Supplement).

This publication has 1 reference indexed in Scilit: